Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmacological Research|April 17, 2019
Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin systemUrsula Quitterer, Said AbdAllaCells|October 23, 2021
Pathological AT1R-B2R Protein Aggregation and PreeclampsiaUrsula Quitterer, Said AbdAllaFrontiers in Medicine|February 15, 2019
Discovery of Pathologic GPCR AggregationUrsula Quitterer, Said AbdAllaBiochemical Pharmacology|January 28, 2014
Vasopressor meets vasodepressor: The AT1-B2 receptor heterodimerUrsula Quitterer, Said AbdAllaSeminars in Nephrology|March 16, 2004
AT1 receptor heterodimers and angiotensin II responsiveness in preeclampsiaUrsula Quitterer, Heinz Lother, Said AbdallaInternational Journal of Molecular Sciences|August 21, 2013
ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's diseaseSaid AbdAlla, Andreas Langer, Xuebin Fu, et al.Biochemical and Biophysical Research Communications|May 24, 2011
A cleavable signal peptide enhances cell surface delivery and heterodimerization of Cerulean-tagged angiotensin II AT1 and bradykinin B2 receptorUrsula Quitterer, Armin Pohl, Andreas Langer, et al.Cell|October 28, 2004
Factor XIIIA transglutaminase crosslinks AT1 receptor dimers of monocytes at the onset of atherosclerosisSaid AbdAlla, Heinz Lother, Andreas Langer, et al.Biomed Research International|December 24, 2015
Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild StressSaid AbdAlla, Ahmed El Hakim, Ahmed Abdelbaset, et al.Journal of Molecular Neuroscience : MN|July 14, 2005
Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertensionSaid AbdAlla, Ahmed Abdel-Baset, Heinz Lother, et al.Pageof 2